Sokal Score for CML

Estimate survival in CML

The global unit selector only affects unanswered questions
1.Age (years)
2.Spleen size (below costal margin)
3.Platelets (x10⁹/L)
4.Blasts (% peripheral blood)
Created by

1. Age (years)

Years
Created by
0/4 completed

About this Calculator

The Sokal score was derived from 813 European and American patients treated from the 1960s-1980s, prior to the era of tyrosine kinase inhibitor therapy. Most individuals in the cohort were treated with single-agent chemotherapeutics. The EUTOS scoring system may offer improved prognostication in the era of TKI therapy

References

Sokal JE, Cox EB, Baccarani M, Tura S, Gomez GA, Robertson JE, et al.

Predicting complete cytogenetic response and subsequent progression-free survival in 2060 patients with CML on imatinib treatment: the EUTOS score.

Circulation. 2011 May 24;123(20):2213-8. doi: 10.1161/CIRCULATIONAHA.110.988568. Epub 2011 May 9.

Legal Notices and Disclaimer

© 2020 QxMD Software Inc., all rights reserved. No part of this service may be reproduced in any way without express written consent of QxMD. This information should not be used for the diagnosis or treatment of any health problem or disease. This information is not intended to replace clinical judgment or guide individual patient care in any manner. Click here for full notice and disclaimer.